Post operative pain. Other acute postprocedural pain
Conditions
Interventions
Intervention 1: Intervention group: The clonidine group (Articaine + Epinephrine + Clonidine, n = 50) received an IANB with 0.2 ml clonidine (Catapressan amp., 150 µg/ml
BoehringerIngelheim, Ingelheim am Rhein, Germany) in addition to 1.8 ml of 4% articaine (Daropakhsh, Tehran, Iran) with 1:100,000 epinephrine. Intervention 2: Control group: The control group (Articai
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Aged 15-60 ASA grade I Have symptomatic irreversible pulpitis in a mandibular posterior tooth
Exclusion criteria
Exclusion criteria: necessity for multi-visit treatments consumption of analgesics or opioids in a week periodontal problems underlying diseases such as diabetes, hypertension or other cardiovascular diseases an allergy or contraindication to clonidine, articaine, or epinephrine active signs of oral infection or inflammation Pregnant or lactating mothers drug abusers, and patients taking a ß-blocker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: 12 h after- 24 h after-36 h after- 48 h after-72 h after procedure. Method of measurement: Heft- parker visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Immediately Before administration- 5 minutes after administration. Method of measurement: digital blood pressure monitor (M3, Omron, omron healthcare co MTD, japan). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Elham Shadmehr
Esfahan University of Medical Sciences
Outcome results
None listed